Topics

Sanofi and Lexicon's Zynquista scores EU approval for type 1 diabetes patients http://bit.ly/2W8eeAK  #pharma #diabetespic.twitter.com/SpYKdGPvnA

07:39 EDT 29 Apr 2019 | Pharmafile

Sanofi and Lexicon's Zynquista scores EU approval for type 1 diabetes patients http://bit.ly/2W8eeAK 

Original Article: Sanofi and Lexicon's Zynquista scores EU approval for type 1 diabetes patients http://bit.ly/2W8eeAK  #pharma #diabetespic.twitter.com/SpYKdGPvnA

NEXT ARTICLE

More From BioPortfolio on "Sanofi and Lexicon's Zynquista scores EU approval for type 1 diabetes patients http://bit.ly/2W8eeAK  #pharma #diabetespic.twitter.com/SpYKdGPvnA"

Quick Search

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Diabetes
Diabetes is a lifelong condition that causes a person's blood sugar level to become too high. The two main types of diabetes are: type 1 diabetes type 2 diabetes In the UK, diabetes affects approximately 2.9 million people. There are a...